BRIEF-Pfizer pausing new clinical trial because of coronavirus outbreak

BRIEF-Pfizer pausing new clinical trial because of coronavirus outbreak

Pfizer Inc:

* Says pausing participant recruitment for three weeks for new and ongoing global interventional studies

* Says pause on clinical studies excludes those recruiting patients with life-threatening conditions who have few or no other therapeutic options Further company coverage: (Reporting By Michael Erman)

Give Feedback

Use this form for editorial or site feedback. We usually reply within 2 to 3 working days.

By submitting, you agree that we may use your email address to respond.